CLINICAL_TRIALS
trial_result
· 2024-08-20
Clinical Trial Update: Ketamine + Mindfulness for Depression [Phase 1, Phase 2]
Summary
Phase 1/2 clinical trial evaluating ketamine in combination with mindfulness for unipolar depression has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Rebecca Price | Conditions: Depression, Unipolar | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-08-20